Update on monoclonal antibody therapy in chronic lymphocytic leukemia
- PMID: 16163170
Update on monoclonal antibody therapy in chronic lymphocytic leukemia
Abstract
Monoclonal antibodies are an evolving treatment modality in chronic lymphocytic leukemia that has the potential to provide more effective and safer targeted therapy. This review provides historical context and detailed analysis of current developments, as well as an outline for future prospects and expectations in this exciting new arena of therapeutics.
Similar articles
-
Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia.Oncogene. 2007 May 28;26(25):3644-53. doi: 10.1038/sj.onc.1210380. Oncogene. 2007. PMID: 17530018 Review.
-
A novel Raji-Burkitt's lymphoma model for preclinical and mechanistic evaluation of CD52-targeted immunotherapeutic agents.Clin Cancer Res. 2008 Jan 15;14(2):569-78. doi: 10.1158/1078-0432.CCR-07-1006. Clin Cancer Res. 2008. PMID: 18223233
-
Antibody therapy in chronic lymphocytic leukemia.Clin Adv Hematol Oncol. 2003 Feb;1(2):89-90. Clin Adv Hematol Oncol. 2003. PMID: 16224382 Review. No abstract available.
-
Alemtuzumab in the treatment of chronic lymphocytic lymphoma.Expert Rev Anticancer Ther. 2008 Apr;8(4):525-33. doi: 10.1586/14737140.8.4.525. Expert Rev Anticancer Ther. 2008. PMID: 18402519 Review.
-
Charting the path to the cure of chronic lymphocytic leukemia: consolidation strategies currently lead the way.Leuk Lymphoma. 2009 Oct;50(10):1557-8. doi: 10.1080/10428190903161083. Leuk Lymphoma. 2009. PMID: 19757304 No abstract available.
Cited by
-
Phase I study of a novel pro-apoptotic drug R-etodolac in patients with B-cell chronic lymphocytic leukemia.Invest New Drugs. 2008 Apr;26(2):139-49. doi: 10.1007/s10637-007-9106-z. Epub 2007 Dec 20. Invest New Drugs. 2008. PMID: 18094935 Clinical Trial.
-
Identifying alemtuzumab as an anti-myeloid cell antiangiogenic therapy for the treatment of ovarian cancer.J Transl Med. 2009 Jun 19;7:49. doi: 10.1186/1479-5876-7-49. J Transl Med. 2009. PMID: 19545375 Free PMC article.